Recalls / Firms / Gilead Sciences, Inc.
Gilead Sciences, Inc.
7 FDA drug recalls on record — 3 Class I.
| Date | Class | Drug | Status |
|---|---|---|---|
| 2024-09-19 | Class I | Veklury | Terminated |
| 2021-12-03 | Class I | Veklury | Terminated |
| 2014-10-01 | Class II | Emtriva | Terminated |
| 2014-09-30 | Class III | Truvada | Terminated |
| 2014-02-19 | Class III | Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) Tab | Terminated |
| 2013-06-20 | Class II | Ambisome | Terminated |
| 2013-01-31 | Class I | Vistide (cidofovir) Injection, 375 mg (75 mg/mL), 5 mL single-use vial, Rx only, Manufactu | Terminated |